Shorted
Painchek logo
PCK
Health Care Equipment & Services

Painchek

Short interest
0.00%
0.00 pp 30d
as of 21 May 2026
Reported shorts
1.5K
Shares on issue
209.007M

Painchek (PCK) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
23 Sept

What could PCK (ASX:PCK) reveal in its latest annual report?

Highlights PCK has released its latest annual report to shareholders, adding a formal reporting milestone to its current ASX news flow. The update sits within the healthcare technology space, with PainChek focused on digital pain assessment and monitoring. Attention now turns to how the annual report brings together the companys recent operational, commercial and corporate developments. PainChek Limited (ASX:PCK), an Australian healthcare technology company focused on digital pain assess...

Continue reading
Kalkine
Neutral
5 Aug

PainChek Revises Key Management Performance Rights Post Share Consolidation

PainChek Ltd (ASX:PCK) has submitted an updated Appendix 3G notification adjusting the number of performance rights held by key management personnel following a recent share consolidation, with the total performance rights on issue now at 1,518,488. Key Highlights Performance rights for four key management executives have been revised after a recent share consolidation, with updated totals for J Murray (96,852), R Harricks (48,426), C Payne (48,426), and A Davey (48,426). This update amends a...

Continue reading
Kalkine
Neutral
5 Aug

PainChek Directors Adam Davey, Ross Harricks, and John Murray Granted 48,426 Performance Rights Each

PainChek Limited (ASX:PCK) announced updates to the relevant interests of directors Adam Davey, Ross Harricks, and John Murray following the issuance of performance rights on 3 August 2026. Each director received 48,426 performance rights at no cost. Key Highlights On 3 August 2026, directors Adam Davey, Ross Harricks, and John Murray each acquired 48,426 performance rights at nil consideration. The issuance corrects previously reported figures filed on 26 June 2026, which were inaccurate due...

Continue reading
Kalkine
Neutral
29 July

Can PainChek (ASX:PCK) Reset Penny Attention?

Highlights PainChek is drawing attention as health technology penny names meeting a more selective market. Today's ASX tone is shaped by small healthcare names are being judged on evidence and cash use. The key question is whether clinical and commercial traction can matter more than hype. A: ustralia's sharemarket has opened with a firmer pulse, and Cann Group (ASX:CAN), a medicinal cannabis producer tied to regulated cultivation, is helping frame why PainChek matters to the latest conversat...

Continue reading